Stimulant drug therapy in hyperactive children: research and clinical implications
Wolraich, M.L.
Pediatrics 60(4): 512-518
1977
ISSN/ISBN: 0031-4005 PMID: 333367 Document Number: 119858
Document emailed within 1 workday
Related Documents
Lucas, B.; Sells, C.J. 1977: Nutrient intake and stimulant drugs in hyperactive children Journal of the American Dietetic Association 70(4): 373-377Janols, L.O.; von Knorring, A.L. 1991: Is drug therapy of hyperactive children justified? Lakartidningen 88(38): 3057-3058; 3061
Ruys-Dudok van Heel, I.; Cohen, A.F.; Wit, J.M.; van der Heijden, A.J.; van den Anker, J.N.; van Meurs, A.H. 1998: Clinical drug research in children: current international guidelines. Committee for Proprietary Medicinal Products Nederlands Tijdschrift Voor Geneeskunde 142(1): 6-9
Winsberg, B.; Matinsky, S.; Kupietz, S.; Richardson, E. 1987: Is there dose-dependent tolerance associated with chronic methylphenidate therapy in hyperactive children: oral dose and plasma considerations Psychopharmacology Bulletin 23(1): 107-110
Schenk, K.D.; Michaelis, A.; Nelson Sapiano, T.; Brown, L.; Weiss, E. 2010: Improving the Lives of Vulnerable Children: Implications of Horizons Research Among Orphans and Other Children Affected by AIDS Public Health Reports 125(2): 325-336
Schenk, K.D.; Michaelis, A.; Sapiano, T.Nelson.; Brown, L.; Weiss, E. 2010: Improving the lives of vulnerable children: implications of Horizons research among orphans and other children affected by AIDS Public Health Reports 125(2): 325-336
Schenk, K.D.; Michaelis, A.; Sapiano, T.Nelson.; Brown, L.; Weiss, E. 2010: Improving the lives of vulnerable children: implications of Horizons research among orphans and other children affected by AIDS Public Health Reports 125(2): 325-336
Slack, C.; Kruger, M. 2005: The South African Medical Research Council's Guidelines on Ethics for Medical Research--implications for HIV-preventive vaccine trials with children South African Medical Journal 95(4): 269-271
1971: Advertising of stimulant drug Medical Journal of Australia 2(24): 1214
Dahlke, F.; Lohaus, A.; Gutzmann, H. 1992: Reliability and clinical concepts underlying global judgments in dementia: implications for clinical research Psychopharmacology Bulletin 28(4): 425-432
Jeske, A.H. 2006: Migraine drug therapy: dental implications Texas Dental Journal 123(2): 190-197
Itil, T.M.; Simeon, J. 1974: Computerized EEG in the prediction of outcome of drug treatment in hyperactive childhood behavior disorders Psychopharmacology Bulletin 10(4): 36
Marmo, E.; Vacca, C.; Saini, R.K.; Fici, F. 1974: Absorption studies with ritodrine an adrenergic beta stimulant drug Bollettino Chimico Farmaceutico 113(10): 559-561
Weiss, S. 1994: Khat--the stimulant drug of Yemen, Ethiopia and other eastern countries Harefuah 126(8): 482-483
Chadha, D.R. 1975: Drug interaction and its clinical implications Journal of the Indian Medical Association 65(7): 198-202
Steinhausen, H.C. 2001: The hyperactive child: diagnosis and therapy Praxis 90(22): 969-973
Buchanan, W.W.; Kean, W.F. 1987: Implications of antirheumatic drug therapy in elderly patients with osteoarthritis Journal of Rheumatology 14(Special Issue): 98-100
Kochman, F.éd.ér.; Karila, L.; Tiravi, S. 2002: Role of psychostimulants in hyperactive children La Revue du Praticien 52(18): 2017-2022
Hillery, J. 1997: The behavioural phenotypes: implications for research and clinical practice Irish Medical Journal 90(5): 181
Grossman, A.; Barenboim, E.; Azaria, B.; Sherer, Y.; Goldstein, L. 2004: Oral drug therapy for erectile dysfunction: overview and aeromedical implications Aviation Space and Environmental Medicine 75(11): 997-1000